Insider Transactions in Q2 2021 at Rvl Pharmaceuticals PLC (RVLP)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Gregory L Cowan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
18,584
-25.06%
|
$37,168
$2.89 P/Share
|
|
Jun 18
2021
|
Fred G Weiss Director |
SELL
Payment of exercise price or tax liability
|
Direct |
18,584
-22.84%
|
$37,168
$2.89 P/Share
|
|
May 18
2021
|
Tina Marie De Vries EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
6,467
-4.1%
|
$19,401
$3.12 P/Share
|
|
May 18
2021
|
Andrew J. Einhorn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,467
-4.1%
|
$19,401
$3.12 P/Share
|
|
May 18
2021
|
Christopher Klein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,467
-2.97%
|
$19,401
$3.12 P/Share
|
|
May 18
2021
|
James Schaub EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,621
-2.08%
|
$19,863
$3.12 P/Share
|